Cargando…
Recent Advances in Toll Like Receptor-Targeting Glycoconjugate Vaccines
Many malignant cell surface carbohydrates resulting from abnormal glycosylation patterns of certain diseases can serve as antigens for the development of vaccines against these diseases. However, carbohydrate antigens are usually poorly immunogenic by themselves, thus they need to be covalently coup...
Autores principales: | Li, Qingjiang, Guo, Zhongwu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6100623/ https://www.ncbi.nlm.nih.gov/pubmed/29966261 http://dx.doi.org/10.3390/molecules23071583 |
Ejemplares similares
-
Recent Advances in the Synthesis of Glycoconjugates for Vaccine Development
por: Colombo, Cinzia, et al.
Publicado: (2018) -
Recent advances in the production of recombinant glycoconjugate vaccines
por: Kay, Emily, et al.
Publicado: (2019) -
Recent advances on smart glycoconjugate vaccines in infections and cancer
por: Anderluh, Marko, et al.
Publicado: (2021) -
Recent Advances in the Chemistry of Glycoconjugate Amphiphiles
por: Latxague, Laurent, et al.
Publicado: (2018) -
Targeting toll-like receptor 7/8 for immunotherapy: recent advances and prospectives
por: Sun, Hao, et al.
Publicado: (2022)